Effectiveness of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache: A Single Blind-Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The International Headache Society classifies cervicogenic headache as a secondary headache caused by a disorder of the cervical spine and its components. Mulligan Concept (SNAG) is a gentle manual therapy that can be applied to the neck area. The myofascial release technique is also a massage-type manual therapy technique that is widely used in physiotherapy to relieve pain and tension in the relevant muscle group. This clinical trial aims to investigate the effectiveness of the Mulligan Concept and myofascial release technique in patients with cervicogenic headaches. The main questions it aims to answer are: 1. Does the Mulligan Concept improve hand grip strength, pressure pain threshold, range of motion, pain frequency, pain intensity, pain duration, number of medications used, daily living activities, and disability in patients with cervicogenic headache? 2. Does myofascial release technique improve hand grip strength, pressure pain threshold, range of motion, pain frequency, pain intensity, pain duration, number of medications used, daily living activities, and disability in patients with cervicogenic headache? Researchers will compare the Mulligan Concept to a myofascial release technique to see which physiotherapy method has more significant results in treating cervicogenic headaches. Participants will: * Undergo the evaluations mentioned above before and after interventions * Undergo Mulligan Concept applications or the myofascial release technique 3 times a week for 4 weeks * Keep a diary of their symptoms and the number of times they use a drug

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 60
Healthy Volunteers: f
View:

• Having been diagnosed with cervicogenic headache according to the International Classification of Headache Disorder-III diagnostic criteria

• Having been diagnosed with cervicogenic headache for more than 3 months

• Having a headache accompanying neck pain

• Having restricted neck joint movement according to the Flexion-Rotation Test

• Having pain between 3 and 8 according to the Visual Analog Scale

• Being between 25-60 years of age

• Agreeing to participate in the study voluntarily

Locations
Other Locations
Turkey
Sefakoy Medipol University Hospital
RECRUITING
Istanbul
Contact Information
Primary
Fatih Bali, PhD Candidate
fatihbali@hotmail.com
+905323937689
Backup
Z. Candan Algun, Professor
calgun@medipol.edu.tr
+905322631630
Time Frame
Start Date: 2024-11-13
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Myofascial Release Group
Twenty participants who will be randomized into the myofascial release group will undergo the myofascial release technique by an experienced physiotherapist 3 times a week for 4 weeks.
Experimental: Mulligan SNAG group
Twenty participants who will be randomized into the Mulligan SNAG group will undergo the Mulligan SNAG technique by an experienced physiotherapist 3 times a week for 4 weeks.
Related Therapeutic Areas
Sponsors
Collaborators: Istanbul Kent University
Leads: Istanbul Medipol University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials